Search This Blog

Tuesday, March 29, 2022

Needham Adjusts PhaseBio Price Target to $10 from $15

 Keeps Buy Rating

https://www.marketscreener.com/quote/stock/PHASEBIO-PHARMACEUTICALS-46661558/news/Needham-Adjusts-PhaseBio-Pharmaceuticals-Price-Target-to-10-from-15-Keeps-Buy-Rating-39887423/

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)